Apple Hit With $634M Verdict in Masimo Blood-Oxygen Case
A California jury ordered Apple to pay Masimo $634 million for infringing a blood-oxygen monitoring patent in Apple Watch models. The verdict raises stakes in a yearslong fight over health-sensor IP, ITC import bans, and Apple’s wearable roadmap.